Neurofilament light chain as a promising biomarker for the diagnosis of depression: a systematic review and meta-analysis

Light chains (NfL), which are associated with axonal neuronal damage, have been identified as a promising biomarker that could aid in the early diagnosis of depression, personalised treatment and monitoring of disease progression. This study used a meta-analysis to assess the potential of plasma NfL as a biomarker for patients with depression.